Skip to main content
Journal cover image

Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.

Publication ,  Journal Article
Wang, Y; Nguyen, FNHL; Allen, JC; Lew, JQL; Tan, NC; Jafar, TH
Published in: BMC nephrology
December 2019

Patients with chronic kidney disease (CKD) are at high risk of end-stage kidney disease (ESKD). The Kidney Failure Risk Equation (KFRE), which predicts ESKD risk among patients with CKD, has not been validated in primary care clinics in Southeast Asia (SEA). Therefore, we aimed to (1) evaluate the performance of existing KFRE equations, (2) recalibrate KFRE for better predictive precision, and (3) identify optimally feasible KFRE thresholds for nephrologist referral and dialysis planning in SEA.All patients with CKD visiting nine primary care clinics from 2010 to 2013 in Singapore were included and applied 4-variable KFRE equations incorporating age, sex, estimated glomerular filtration rate (eGFR), and albumin-to-creatinine ratio (ACR). ESKD onset within two and five years were acquired via linkage to the Singapore Renal Registry. A weighted Brier score (the squared difference between observed vs predicted ESKD risks), bias (the median difference between observed vs predicted ESKD risks) and precision (the interquartile range of the bias) were used to select the best-calibrated KFRE equation.The recalibrated KFRE (named Recalibrated Pooled KFRE SEA) performed better than existing and other recalibrated KFRE equations in terms of having a smaller Brier score (square root: 2.8% vs. 4.0-9.3% at 5 years; 2.0% vs. 6.1-9.1% at 2 years), less bias (2.5% vs. 3.3-5.2% at 5 years; 1.8% vs. 3.2-3.6% at 2 years), and improved precision (0.5% vs. 1.7-5.2% at 5 years; 0.5% vs. 3.8-4.2% at 2 years). Area under ROC curve for the Recalibrated Pooled KFRE SEA equations were 0.94 (95% confidence interval [CI]: 0.93 to 0.95) at 5 years and 0.96 (95% CI: 0.95 to 0.97) at 2 years. The optimally feasible KFRE thresholds were > 10-16% for 5-year nephrologist referral and > 45% for 2-year dialysis planning. Using the Recalibrated Pooled KFRE SEA, an estimated 82 and 89% ESKD events were included among 10% of subjects at highest estimated risk of ESKD at 5-year and 2-year, respectively.The Recalibrated Pooled KFRE SEA performs better than existing KFREs and warrants implementation in primary care settings in SEA.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

BMC nephrology

DOI

EISSN

1471-2369

ISSN

1471-2369

Publication Date

December 2019

Volume

20

Issue

1

Start / End Page

451

Related Subject Headings

  • Urology & Nephrology
  • Singapore
  • Risk Assessment
  • Reproducibility of Results
  • Renal Insufficiency
  • Middle Aged
  • Male
  • Kidney Function Tests
  • Kidney Failure, Chronic
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wang, Y., Nguyen, F. N. H. L., Allen, J. C., Lew, J. Q. L., Tan, N. C., & Jafar, T. H. (2019). Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia. BMC Nephrology, 20(1), 451. https://doi.org/10.1186/s12882-019-1643-0
Wang, Yeli, Francis Ngoc Hoang Long Nguyen, John C. Allen, Jasmine Quan Lan Lew, Ngiap Chuan Tan, and Tazeen H. Jafar. “Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.BMC Nephrology 20, no. 1 (December 2019): 451. https://doi.org/10.1186/s12882-019-1643-0.
Wang Y, Nguyen FNHL, Allen JC, Lew JQL, Tan NC, Jafar TH. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia. BMC nephrology. 2019 Dec;20(1):451.
Wang, Yeli, et al. “Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.BMC Nephrology, vol. 20, no. 1, Dec. 2019, p. 451. Epmc, doi:10.1186/s12882-019-1643-0.
Wang Y, Nguyen FNHL, Allen JC, Lew JQL, Tan NC, Jafar TH. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia. BMC nephrology. 2019 Dec;20(1):451.
Journal cover image

Published In

BMC nephrology

DOI

EISSN

1471-2369

ISSN

1471-2369

Publication Date

December 2019

Volume

20

Issue

1

Start / End Page

451

Related Subject Headings

  • Urology & Nephrology
  • Singapore
  • Risk Assessment
  • Reproducibility of Results
  • Renal Insufficiency
  • Middle Aged
  • Male
  • Kidney Function Tests
  • Kidney Failure, Chronic
  • Humans